ProShare Advisors’s Palisade Bio PALI Stock Holding History

ProShare Advisors’s Portfolio PALI Stock Details PALI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$40.4K	Buy	+19,325	New	+$38K	﹤0.01%	1859
2015 Q2	–	Hold	0	–	-$25K	–	1743
2015 Q1	–	Hold	0	–	–	–	1899
2014 Q4	–	Hold	0	–	–	–	1932
2014 Q3	–	Hold	0	–	–	–	2186
2014 Q2	–	Hold	0	–	–	–	2286

Other funds holding PALI

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BGI

B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

ProShare Advisors's PALI Position: Q2 2026 in Review

ProShare Advisors opened a new position in Palisade Bio (PALI) in Q2 2026: 19,325 shares worth $40.4K. The stake represents ﹤0.01% of the portfolio and ranks #1859 among its holdings.

124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

ProShare Advisors held 19,325 shares of Palisade Bio worth $40.4K as of Q2 2026.
Palisade Bio was a new ProShare Advisors position in Q2 2026.
Palisade Bio made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #1859 holding.
124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.